Trial: 201609087

A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

Phase

II (Cancer Control)

Principal Investigator

Oh, Stephen

Disease Site

Myeloid and Monocytic Leukemia; Myeloproliferative Disease

Learn more about this study at: clinicaltrials.gov